These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11433194)

  • 21. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [S-100 protein and human cerebral tumors].
    Benda P
    Rev Neurol (Paris); 1968 May; 118(5):368-72. PubMed ID: 4301327
    [No Abstract]   [Full Text] [Related]  

  • 23. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.
    Nakagawa T; Kabuto M; Kubota T; Kodera T; Sato K
    Anticancer Res; 1999; 19(4B):2963-8. PubMed ID: 10652580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteine cathepsins in human cancer.
    Jedeszko C; Sloane BF
    Biol Chem; 2004 Nov; 385(11):1017-27. PubMed ID: 15576321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin B and cysteine protease inhibitors in human osteoarthritis.
    Martel-Pelletier J; Cloutier JM; Pelletier JP
    J Orthop Res; 1990 May; 8(3):336-44. PubMed ID: 2324852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysosomal enzymes, cathepsins in brain tumour invasion.
    Levicar N; Strojnik T; Kos J; Dewey RA; Pilkington GJ; Lah TT
    J Neurooncol; 2002 May; 58(1):21-32. PubMed ID: 12160137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Bcl2 proto-oncogene in primary tumors of the central nervous system.
    Tyagi D; Sharma BS; Gupta SK; Kaul D; Vasishta RK; Khosla VK
    Neurol India; 2002 Sep; 50(3):290-4. PubMed ID: 12391455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor.
    Biroc SL; Gay S; Hummel K; Magill C; Palmer JT; Spencer DR; Sa S; Klaus JL; Michel BA; Rasnick D; Gay RE
    Arthritis Rheum; 2001 Mar; 44(3):703-11. PubMed ID: 11263786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midgut cysteine protease-inhibiting activity in Trichoplusia ni protects the peritrophic membrane from degradation by plant cysteine proteases.
    Li C; Song X; Li G; Wang P
    Insect Biochem Mol Biol; 2009 Oct; 39(10):726-34. PubMed ID: 19729065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actin content and actin polymerization in hepatoma Morris 5123 tumor bearing rats after treatment with cysteine protease inhibitor and vitamin E.
    Sebzda T; Saleh Y; Malicka-Blaszkiewicz M; Nowak D; Siewinski M; Ziolkowski P; Kopec W
    J Exp Ther Oncol; 2005; 5(1):23-9. PubMed ID: 16416598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of neoplasm-specific cathepsin B by cysteine-protease inhibitors present in cancerous exudates].
    Keppler D; Pagano M; Dalet-Fumeron V; Engler R
    C R Acad Sci III; 1985; 300(13):471-4. PubMed ID: 3924358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Rac3 in human brain tumors.
    Hwang SL; Chang JH; Cheng TS; Sy WD; Lieu AS; Lin CL; Lee KS; Howng SL; Hong YR
    J Clin Neurosci; 2005 Jun; 12(5):571-4. PubMed ID: 15993075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
    Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
    Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipapain activity in the serum of patients with breast cancer.
    Kilar E; Gworys B; Skiba T; Gburek J; Gołąb K; Janocha A; Siewiński M
    Cancer Biomark; 2015; 15(1):99-102. PubMed ID: 25524947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permeability in brain tumors.
    Tator CH; Schwartz ML
    J Neurosurg; 1971 Mar; 34(3):460-2. PubMed ID: 5547331
    [No Abstract]   [Full Text] [Related]  

  • 39. Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumors.
    Schaller HC; Schilling E; Theilmann L; Bodenmüller H; Sachsenheimer W
    J Neurooncol; 1988 Nov; 6(3):251-8. PubMed ID: 3225643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta-like activity in tumors of the central nervous system.
    Clark WC; Bressler J
    J Neurosurg; 1988 Jun; 68(6):920-4. PubMed ID: 3163723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.